Hematopoietic Cell Transplantation in the Treatment of Adult Acute Lymphoblastic Leukemia: Updated 2019 Evidence-Based Review from the American Society for Transplantation and Cellular Therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Hematopoietic Cell Transplantation in the Treatment of Adult Acute Lymphoblastic Leukemia: Updated 2019 Evidence-Based Review from the American Society for Transplantation and Cellular Therapy

Published:2019-11 Issue:11 Volume:25 Page:2113-2123
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

DeFilipp Zachariah,Advani Anjali S.,Bachanova Veronika,Cassaday Ryan D.,Deangelo Daniel J.,Kebriaei Partow,Rowe Jacob M.,Seftel Matthew D.,Stock Wendy,Tallman Martin S.,Fanning Suzanne,Inamoto Yoshihiro,Kansagra Ankit,Johnston Laura,Nagler Arnon,Sauter Craig S.,Savani Bipin N.,Perales Miguel-Angel,Carpenter Paul A.,Larson Richard A.,Weisdorf Daniel

Funder

Amgen

Pfizer

Novartis

Gilead Sciences

Merck

Vanda Pharmaceuticals

Pharmaceuticals

Teva Pharmaceutical

and

Sanofi

Genzyme

AbbVie

Bristol-Myers Squibb

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference119 articles.

1. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute lymphoblastic leukemia in adults: an evidence-based review;Hahn;Biol Blood Marrow Transplant,2006

2. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of adult acute lymphoblastic leukemia: update of the 2006 evidence-based review;Oliansky;Biol Blood Marrow Transplant,2012

3. A new system for grading recommendations in evidence based guidelines;Harbour;BMJ,2001

4. Methodology for updating published evidence-based reviews evaluating the role of blood and marrow transplantation in the treatment of selected diseases: a policy statement by the American Society for Blood and Marrow Transplantation;Jones;Biol Blood Marrow Transplant,2009

5. Outcome of treatment in adults with acute lymphoblastic leukemia: analysis of the LALA-94 trial;Thomas;J Clin Oncol,2004

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Allogeneic Hematopoietic Cell Transplantation for Patients With Acute Lymphoblastic Leukemia;Manual of Hematopoietic Cell Transplantation and Cellular Therapies;2024

2. Myeloablative or reduced-intensity/non-myeloablative hematopoietic cell transplantation for Philadelphia-positive acute lymphoblastic leukemia in adults older than 40 years old — a secondary analysis of a CIBMTR database;Annals of Hematology;2023-11-09

3. Dose Escalation of Total Marrow and Lymphoid Irradiation Prior to Allogeneic Stem Cell Transplantation treating for Acute Leukemia and Lymphoma;2023-11-07

4. SOHO State of the Art Updates and Next Questions | Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia in Adults: Therapeutic Options and Challenges in 2023;Clinical Lymphoma Myeloma and Leukemia;2023-11

5. Next-generation sequencing–based MRD in adults with ALL undergoing hematopoietic cell transplantation;Blood Advances;2023-07-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3